The 1027(th) target candidate in stroke: Will NADPH oxidase hold up?

As recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Radermacher, Kim A, Wingler, Kirstin, Kleikers, Pamela, Altenhöfer, Sebastian, JR Hermans, Johannes, Kleinschnitz, Christoph, HHW Schmidt, Harald
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2012
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403875/
https://ncbi.nlm.nih.gov/pubmed/22625431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2040-7378-4-11
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk